Trial · NCT01117766
Results by group86
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 86
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Dynamic Allodynia Intensity at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 3 (Visits 3 and 6) (n=15,16) | -1.09 | Standard Deviation 1.735 | scores on a scale |
| Mean Change From Baseline in Dynamic Allodynia Intensity at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 3 (Visits 3 and 6) (n=15,16) | -1.16 | Standard Deviation 1.730 | scores on a scale |
| Mean Change From Baseline in Dynamic Allodynia Intensity at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 4 (Visits 4 and 7) (n=18,21) | -1.31 | Standard Deviation 1.924 | scores on a scale |
| Mean Change From Baseline in Dynamic Allodynia Intensity at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 4 (Visits 4 and 7) (n=18,21) | -0.67 | Standard Deviation 1.984 | scores on a scale |
| Mean Change From Baseline in Dynamic Allodynia Area at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 3 (Visits 3 and 6) (n=16,17) | -53.441 | Standard Deviation 114.7084 | cm2 |
| Mean Change From Baseline in Dynamic Allodynia Area at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 3 (Visits 3 and 6) (n=16,17) | -49.180 | Standard Deviation 94.3329 | cm2 |
| Mean Change From Baseline in Dynamic Allodynia Area at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 4 (Visits 4 and 7) (n=17,20) | -49.808 | Standard Deviation 100.2094 | cm2 |
| Mean Change From Baseline in Dynamic Allodynia Area at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 4 (Visits 4 and 7) (n=17,20) | -18.921 | Standard Deviation 104.3942 | cm2 |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 3 (Visits 3 and 6) (Size 8, n=15,16) | -0.133 | Standard Deviation 1.7494 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 3 (Visits 3 and 6) (Size 8, n=15,16) | 0.417 | Standard Deviation 2.6063 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 3 (Visits 3 and 6) (Size 16, n=15,16) | -1.356 | Standard Deviation 2.4800 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 3 (Visits 3 and 6) (Size 16, n=15,16) | 0.208 | Standard Deviation 2.6412 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 3 (Visits 3 and 6) (Size 32, n=15,16) | -0.200 | Standard Deviation 1.8551 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 3 (Visits 3 and 6) (Size 32, n=15,16) | -0.188 | Standard Deviation 2.1636 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 3 (Visits 3 and 6) (Size 64, n=15,16) | -1.128 | Standard Deviation 2.0304 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 3 (Visits 3 and 6) (Size 64, n=15,16) | 0.561 | Standard Deviation 2.9543 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 3 (Visits 3 and 6) (Size 128, n=15,16) | -1.267 | Standard Deviation 1.6868 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 3 (Visits 3 and 6) (Size 128, n=15,16) | -0.097 | Standard Deviation 1.3385 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Pregabalin | Week 3 (Visits 3 and 6) (Size 256, n=15,16) | -0.773 | Standard Deviation 2.2420 | scores on a scale |
| Mean Change From Baseline in Mechanical Pain Sensitivity (Von Frey) at Visits 3 and 6 and Visits 4 and 7 | Placebo | Week 3 (Visits 3 and 6) (Size 256, n=15,16) | -0.171 | Standard Deviation 1.4133 | scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01117766/results